SCHEMBL7365849

SCHEMBL7365849

CCOC(=O)c1cccnc1Oc1ccc(Cl)c(C(C)=O)c1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.51
L3MBTL1 Q9Y468 3/20 0.48
MAPK1 P28482 1/20 0.48
ALDH1A1 P00352 4/20 0.47
KMT2A Q03164 1/20 0.47
ATM Q13315 1/20 0.47
POLB P06746 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
RAB9A P51151 2/20 0.45
NPC1 O15118 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
NPSR1 Q6W5P4 1/20 0.44
HPGD P15428 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
CYP4F2 P78329 1/20 0.43
CYP4A11 Q02928 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7368546 0.84 RAB9A (0.50) ALDH1A1POLBTDP1RAB9ASMN1; SMN2
SCHEMBL3454297 0.82 CYP1A2 (0.62) CYP1A2L3MBTL1MAPK1ALDH1A1KMT2A
SCHEMBL7367524 0.81 ALDH1A1 (0.59) CYP1A2L3MBTL1ALDH1A1KMT2APOLB
SCHEMBL7369272 0.81 L3MBTL1 (0.50) CYP1A2L3MBTL1MAPK1ALDH1A1KMT2A
SCHEMBL8560540 0.80 GAA (0.62) CYP1A2L3MBTL1MAPK1ALDH1A1KMT2A
SCHEMBL7369514 0.80 CARM1 (0.52) L3MBTL1MAPK1ALDH1A1KMT2AATM
SCHEMBL20831533 0.79 TDP1 (0.72) CYP1A2L3MBTL1MAPK1ALDH1A1POLB
SCHEMBL7374239 0.79 KMT2A (0.60) CYP1A2L3MBTL1ALDH1A1KMT2ATDP1
SCHEMBL3454518 0.78 POLB (0.61) L3MBTL1MAPK1ALDH1A1KMT2AATM
SCHEMBL15912476 0.78 TDP1 (0.57) CYP1A2L3MBTL1MAPK1ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380218-B1 FOR THERAPY OF RESPIRATORY, ALLERGIC, AND INFLAMMATORY DISORDERS COMPRISING ASTHMA, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ACUTE RESPIRATORY DISEASE SYNDROME, PULMONARY HYPERSENSITIVITY, AND ALLERGIC RHINITIS IN A MAMMAL PFIZER INC 2002-04-30 US disclosed
EP-0971894-A1 NICOTINAMIDE DERIVATIVES Pfizer Products Inc. (US) 2000-01-19 EP disclosed
WO-1998045268-A1 NICOTINAMIDE DERIVATIVES PFIZER PRODUCTS INC. (US) 1998-10-15 WO disclosed